151 related articles for article (PubMed ID: 18848724)
41. The effect of polymer composition on the gelation behavior of PLGA-g-PEG biodegradable thermoreversible gels.
Tarasevich BJ; Gutowska A; Li XS; Jeong BM
J Biomed Mater Res A; 2009 Apr; 89(1):248-54. PubMed ID: 18464255
[TBL] [Abstract][Full Text] [Related]
42. [Preparation and degradation behavior of PELGE nanoparticles].
Duan Y; Zhang Z; Tang Y; Lin Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):921-5. PubMed ID: 15646333
[TBL] [Abstract][Full Text] [Related]
43. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
44. Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.
Cenni E; Granchi D; Avnet S; Fotia C; Salerno M; Micieli D; Sarpietro MG; Pignatello R; Castelli F; Baldini N
Biomaterials; 2008 Apr; 29(10):1400-11. PubMed ID: 18191195
[TBL] [Abstract][Full Text] [Related]
45. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Derakhshandeh K; Erfan M; Dadashzadeh S
Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
[TBL] [Abstract][Full Text] [Related]
46. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
47. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
48. Fabrication and characterization of permeable degradable poly(DL-lactide-co-glycolide) (PLGA) hollow fiber phase inversion membranes for use as nerve tract guidance channels.
Wen X; Tresco PA
Biomaterials; 2006 Jul; 27(20):3800-9. PubMed ID: 16564567
[TBL] [Abstract][Full Text] [Related]
49. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
[TBL] [Abstract][Full Text] [Related]
50. Poly(L-lactide)-b-poly(ethylene oxide) copolymers with different arms: hydrophilicity, biodegradable nanoparticles, in vitro degradation, and drug-release behavior.
Liu Q; Cai C; Dong CM
J Biomed Mater Res A; 2009 Mar; 88(4):990-9. PubMed ID: 18384173
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer.
Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A
J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589
[TBL] [Abstract][Full Text] [Related]
52. Effect of encapsulation or grafting on release kinetics of recombinant human bone morphogenetic protein-2 from self-assembled poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
Mercado AE; Jabbari E
Microsc Res Tech; 2010 Sep; 73(9):824-33. PubMed ID: 20232367
[TBL] [Abstract][Full Text] [Related]
53. Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats.
S S; S M; P S L S; S S; S B; V P
Int J Biol Macromol; 2017 Feb; 95():1190-1198. PubMed ID: 27825822
[TBL] [Abstract][Full Text] [Related]
54. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
Lalani J; Rathi M; Lalan M; Misra A
Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442
[TBL] [Abstract][Full Text] [Related]
55. Vectorization of copper complexes via biocompatible and biodegradable PLGA nanoparticles.
Courant T; Roullin VG; Cadiou C; Delavoie F; Molinari M; Andry MC; Gafa V; Chuburu F
Nanotechnology; 2010 Apr; 21(16):165101. PubMed ID: 20348590
[TBL] [Abstract][Full Text] [Related]
56. Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery.
Nie Y; Zhang ZR; He B; Gu Z
J Biomater Appl; 2012 May; 26(8):893-916. PubMed ID: 21273262
[TBL] [Abstract][Full Text] [Related]
57. The effect of monomer order on the hydrolysis of biodegradable poly(lactic-co-glycolic acid) repeating sequence copolymers.
Li J; Rothstein SN; Little SR; Edenborn HM; Meyer TY
J Am Chem Soc; 2012 Oct; 134(39):16352-9. PubMed ID: 22950719
[TBL] [Abstract][Full Text] [Related]
58. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
Yang J; Sun H; Song C
Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795
[TBL] [Abstract][Full Text] [Related]
59. Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments.
Simonoska Crcarevska M; Geskovski N; Calis S; Dimchevska S; Kuzmanovska S; Petruševski G; Kajdžanoska M; Ugarkovic S; Goracinova K
Eur J Pharm Sci; 2013 Apr; 49(1):65-80. PubMed ID: 23439240
[TBL] [Abstract][Full Text] [Related]
60. The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment.
Zhang X; Dong Y; Zeng X; Liang X; Li X; Tao W; Chen H; Jiang Y; Mei L; Feng SS
Biomaterials; 2014 Feb; 35(6):1932-43. PubMed ID: 24315578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
